FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Three female babies Number of female fetuses
Three hundred and sixty degree translocation of macula Translocation of retina (procedure)
Three male babies Number of male fetuses
Three male babies Number of male fetuses
Three previous induced terminations of pregnancy Past pregnancy history of multiple induced termination of pregnancy
Throat anti-infective preparation Product manufactured as oromucosal dose form (product)
Throat preparation Product manufactured as oromucosal dose form (product)
Thrombocytopenia NOS Thrombocytopenic disorder
Thrombocytopenia NOS Thrombocytopenic disorder
Thrombocytopenia: [congenital purpura] or [hereditary NEC] Hereditary thrombocytopenic disorder (disorder)
Thrombolytic agent Thrombolytic agent (substance)
Thrombophilia due to acquired protein C deficiency Acquired protein C deficiency (disorder)
Thrombophilia due to acquired protein S deficiency Acquired protein S deficiency
Thrombosis of renal vein Thrombosis of renal vein
Thrombosis of vein NOS Venous thrombosis
Thrombosis of vein NOS Venous thrombosis
Thrombotic microangiopathy NOS Thrombotic microangiopathy (disorder)
Thrombus due to any device, implant AND/OR graft Thrombosis (disorder)
Thumb X-ray Plain X-ray of thumb (procedure)
Thumb X-ray Plain X-ray of thumb (procedure)
Thumb X-ray Plain X-ray of thumb (procedure)
Thumb pulp flap Flap (substance)
Thymoma - category Thymoma
Thymoma, no International Classification of Diseases for Oncology subtype Thymoma of uncertain behaviour
Thymoma, type A Thymoma, type A, malignant
Thymoma, type AB Thymoma, type AB, malignant
Thymoma, type B1 Thymoma, type B1, malignant
Thymoma, type B2 Thymoma, type B2, malignant
Thymoma, type B3 Thymoma, type B3, malignant
Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial Product containing only thymalfasin (medicinal product)
Thymosin alpha 1 1.6mg powder for injection solution vial + diluent Product containing only thymalfasin (medicinal product)
Thymoxamine 0.5% conventional release eye drops Product containing only moxisylyte in ocular dose form (medicinal product form)
Thymoxamine 0.5% preservative-free eye drops Product containing only moxisylyte in ocular dose form (medicinal product form)
Thyroid TNM finding American Joint Committee on Cancer allowable value
Thyroid disease monitoring NOS Thyroid disease monitoring
Thyroid disease monitoring NOS Thyroid disease monitoring
Thyroid eye disease with exophthalmos Exophthalmos due to thyroid eye disease (disorder)
Thyroid eye disease with strabismus Exophthalmos due to thyroid eye disease (disorder)
Thyroid gland excision Thyroidectomy
Thyroid incision NOS Incision of thyroid
Thyroid incision NOS Incision of thyroid
Thyroid related antibody Thyroid antibody
Thyroiditis NOS Thyroiditis
Thyroiditis NOS Thyroiditis
Thyrotoxicosis NOS Thyrotoxicosis
Thyrotoxicosis NOS Thyrotoxicosis
Thyrotropin alfa 0.9mg/mL powder for injection solution vial Thyrotrophin only product
Thyrotropin alfa 1.1mg/vial powder Thyrotrophin only product
Thyroxine sodium 100micrograms tablet Levothyroxine sodium anhydrous 100 microgram oral tablet
Thyroxine sodium 25micrograms tablet Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug)
Thyroxine sodium 50micrograms tablet Levothyroxine sodium anhydrous 50 microgram oral tablet
Tibia X-ray Plain X-ray of tibia
Tic disorder unspecified Tic (finding)
Tic disorder unspecified Tic (finding)
Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 1g powder for injection solution vial Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 20g powder for injection solution vial Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug)
Ticarcillin disodium 3g powder for injection solution vial Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
Tiludronate disodium Product containing tiludronic acid (medicinal product)
Time since symptom started NOS Symptom findings in relation to start time
Time since symptom started NOS Symptom findings in relation to start time
Time symptom lasts NOS Symptom findings in relation to time lasts (finding)
Time symptom lasts NOS Time symptom lasts
Time zone syndrome Jet lag (finding)
Timed unsupported steady stand test Timed unsupported steady stand time
Timolol maleate 0.25% ophthalmic solution Timolol (as timolol maleate) 2.5 mg/mL eye drops
Timolol maleate 0.5% Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Timolol maleate 0.5% ophthalmic solution Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Timolol maleate+bendroflumethiazide Product containing bendroflumethiazide and timolol (medicinal product)
Tinnitus symptom NOS Tinnitus
Tinnitus symptom NOS Tinnitus
Tiotropium 18microgram inhalation powder capsule Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation
Tiotropium 18microgram inhalation powder capsule with device Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation
Tis (0): Carcinoma in situ (limited to fallopian tube mucosa) American Joint Committee on Cancer cTis (qualifier value)
Tis (0): Carcinoma in situ (vagina) American Joint Committee on Cancer cTis (qualifier value)
Tis category American Joint Committee on Cancer cTis (qualifier value)
Tis: Carcinoma in situ ("flat tumor" of urinary bladder) American Joint Committee on Cancer cTis (qualifier value)
Tis: Carcinoma in situ (endometrium/uterine cervix) American Joint Committee on Cancer cTis (qualifier value)
Tis: Carcinoma in situ American Joint Committee on Cancer cTis (qualifier value)
Tis: Epithelium only (carcinoma in situ, no invasion) American Joint Committee on Cancer cTis (qualifier value)
Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis) American Joint Committee on Cancer cTis (qualifier value)
Tis: Tumor invades lamina propria (gastrointestinal tumor) American Joint Committee on Cancer cTis(LAMN) (qualifier value)
Tis: Tumor invades muscularis mucosae (colon/rectum) American Joint Committee on Cancer cTis (qualifier value)
Tissue culture for chromosome analysis, more complex procedure with special extra counts Chromosome analysis
Tissue cytology NOS Cytologic test
Tissue cytology NOS Cytologic test
Tissue disruption operation NOS Tissue disruption operation
Tissue disruption operation NOS Tissue disruption operation
Tissue injection for local action Injection
Tissue injection for local action NOS Injection
Tissue injection for local action NOS Injection
Tissue kallikrein Kininogen
Tissue processing technique, complex, embed, cut and stain, per autopsy Tissue processing technique
Tissue processing technique, complex, embed, cut and stain, per surgical specimen Tissue processing technique
Titanium dioxide 20% paste Product containing only titanium dioxide (medicinal product)
Tobacco consumption NOS Tobacco use and exposure
Tobacco consumption NOS Tobacco use and exposure
Tobacco dependence with current use Tobacco dependence syndrome
Tobacco processor NOS Tobacco processor
Tobacco processor NOS Tobacco processor
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)

Start Previous Page 210 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start